CUSIP 85209E109COMSPRBQ2 2025
47 filings · latest Aug 13, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 1.00M | $72.5K |
| 2 | Acadian Asset Management LLC | 1.05M | $74 |
| 3 | Caldwell Sutter Capital, Inc. | 1.0K | $73 |
| 4 | Jan 10, 2025 | Rivervest Venture Fund III, L.P. | 13D/A | 4.2% | — | SEC |
| 5 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 5.0% | 2.17M | SEC |
| 6 | Nov 14, 2024 | 5am Opportunities II, L.P. | 13G/A | 4.1% | 1.77M | SEC |
| 7 | Nov 12, 2024 | Radoff Bradley Louis | 13G/A | 1.0% | 175.0K | SEC |
| 8 | Oct 23, 2024 | Rosalind Advisors, Inc. | 13G/A | — | — | SEC |
| 9 | Apr 25, 2024 | Rosalind Advisors, Inc. | 13G/A | 3.7% | 1.51M | SEC |
| 10 | Mar 28, 2024 | Novo Holdings A/S | 13D/A | 3.9% | 1.66M | SEC |
See the full Schedule 13D/13G history for Spruce Biosciences Inc.
Unlock full history